SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Walgreens Boots Alliance, Inc. – ‘8-K’ for 1/26/23

On:  Tuesday, 1/31/23, at 5:23pm ET   ·   For:  1/26/23   ·   Accession #:  1193125-23-20487   ·   File #:  1-36759

Previous ‘8-K’:  ‘8-K’ on / for 1/5/23   ·   Next:  ‘8-K/A’ on 3/21/23 for 1/3/23   ·   Latest:  ‘8-K’ on 3/28/24 for 3/27/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/31/23  Walgreens Boots Alliance, Inc.    8-K:5,9     1/26/23   12:421K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     47K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML    170K 
 7: R1          Document and Entity Information                     HTML     54K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- d103023d8k_htm                      XML     21K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.DEF  XBRL Definitions -- wba-20230126_def                 XML     42K 
 5: EX-101.LAB  XBRL Labels -- wba-20230126_lab                      XML     70K 
 6: EX-101.PRE  XBRL Presentations -- wba-20230126_pre               XML     44K 
 3: EX-101.SCH  XBRL Schema -- wba-20230126                          XSD     16K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    22K 
12: ZIP         XBRL Zipped Folder -- 0001193125-23-020487-xbrl      Zip     64K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX: 
  8-K  
 i false  i 0001618921  i --08-31 0001618921 2023-01-26 2023-01-26 0001618921 us-gaap:CommonStockMember 2023-01-26 2023-01-26 0001618921 wba:A3600NotesPayableDue2025Member 2023-01-26 2023-01-26 0001618921 wba:A2125NotesPayableDue2026Member 2023-01-26 2023-01-26

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM  i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  i January 26, 2023

 i WALGREENS BOOTS ALLIANCE, INC.

(Exact name of registrant as specified in its charter)

 

 i Delaware    i 001-36759    i 47-1758322

(State or other jurisdiction

of incorporation)

  (Commission File
Number)
 

(IRS Employer

Identification Number)

 

 i 108 Wilmot Road,  i Deerfield,  i Illinois    i 60015
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code:  i (847)  i 315-2500

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

   i 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   i 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   i 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   i 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

 i Common Stock, $0.01 par value    i WBA    i The Nasdaq Stock Market LLC
 i 3.600% Walgreens Boots Alliance, Inc. notes due 2025    i WBA25    i The Nasdaq Stock Market LLC
 i 2.125% Walgreens Boots Alliance, Inc. notes due 2026    i WBA26    i The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 


Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On January 26, 2023, the Board of Directors (the “Board”) of Walgreens Boots Alliance, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Governance Committee, approved and adopted, effective immediately, the Company’s Amended and Restated Bylaws (as amended and restated, the Bylaws). The amendments to the Bylaws include: (a) modifications to the provisions relating to the availability of lists of stockholders entitled to vote at stockholder meetings in Article II, Section 2.6 to reflect recent amendments to the Delaware General Corporation Law (the “DGCL”); (b) revisions to Article II, Section 2.8 to require that any stockholder directly or indirectly soliciting proxies from other stockholders use a proxy card color other than white; (c) revisions to Article II, Sections 2.15, 2.16 and 2.17 with respect to the notification and other requirements related to nominations of directors and solicitations of proxies, including requiring compliance with Rule 14a-19 under the Securities Exchange Act of 1934, as amended, and requiring that stockholder nominees for director provide specified information and sit for interviews with the Board and its committees, if requested; (d) modifications to Article II, Section 2.18 to provide that abstentions and directions to withhold authority will not be considered votes cast in determining the outcome of any election of directors; (e) inclusion of a new Section 3.14 in Article III allowing the Board and committees of the Board to conduct business in the event of an emergency as permitted under the DGCL, and (f) other technical, ministerial, clarifying and conforming changes.

The foregoing summary of the amendments to the Company’s Bylaws is qualified in all respects by reference to the text of the Bylaws, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 5.07. Submission of Matters to a Vote of Security Holders.

(a) The Company held its Annual Meeting on January 26, 2023.

(b) Set forth below are the voting results for each of the proposals submitted to a vote of the Company’s stockholders at the Annual Meeting:

Proposal No. 1: The stockholders voted for the election of the following directors to serve on the Board until the next Annual Meeting of Stockholders or until their successors are elected and qualified (or any such director’s earlier death, resignation or removal):

 

    

Votes For

    

Votes
Against

    

Abstentions

    

Broker

Non-Votes

 

Janice M. Babiak

     622,276,609        9,080,379        1,592,400        111,155,434  

Inderpal S. Bhandari

     625,620,829        5,483,849        1,844,710        111,155,434  

Rosalind G. Brewer

     622,191,606        9,118,030        1,639,752        111,155,434  

Ginger L. Graham

     605,098,862        26,244,952        1,605,574        111,155,434  

Bryan C. Hanson

     621,865,913        9,450,283        1,633,192        111,155,434  

Valerie B. Jarrett

     610,461,150        21,018,256        1,469,982        111,155,434  

John A. Lederer

     614,689,631        16,624,470        1,635,287        111,155,434  

Dominic P. Murphy

     624,122,642        7,108,801        1,717,945        111,155,434  

Stefano Pessina

     613,517,812        17,700,774        1,730,802        111,155,434  

Nancy M. Schlichting

     592,861,750        38,355,706        1,731,932        111,155,434  

Proposal No. 2: The proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers, as set forth in the proxy statement for the Annual Meeting, was approved. There were 555,423,218 votes for, 73,571,554 votes against, and 3,954,616 abstentions. There were 111,155,434 broker non-votes on this proposal.


Proposal No. 3: The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2023 was approved. There were 715,841,987 votes for, 26,216,090 votes against, and 2,046,745 abstentions.

Proposal No. 4: The stockholder proposal requesting report on public health costs due to tobacco product sales and the impact on overall market returns was not approved. There were 64,828,489 votes for, 562,332,664 votes against, and 5,788,235 abstentions. There were 111,155,434 broker non-votes on this proposal.

Proposal No. 5: The stockholder proposal requesting an independent board chairman was not approved. There were 214,178,740 votes for, 416,228,718 votes against, and 2,541,930 abstentions. There were 111,155,434 broker non-votes on this proposal.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit   

Description

3.1    Amended and Restated Bylaws of Walgreens Boots Alliance, Inc.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    WALGREENS BOOTS ALLIANCE, INC.
Date: January 31, 2023     By:  

/s/ Joseph B. Amsbary Jr.

    Title:   Senior Vice President, Corporate Secretary

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:1/31/23SC 13G/A
For Period end:1/26/234,  DEF 14A
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/28/24  Walgreens Boots Alliance, Inc.    10-Q        2/29/24   97:12M
 1/04/24  Walgreens Boots Alliance, Inc.    10-Q       11/30/23   98:11M
11/22/23  Walgreens Boots Alliance, Inc.    10-K/A      8/31/23   17:513K
10/12/23  Walgreens Boots Alliance, Inc.    10-K        8/31/23  138:20M
Top
Filing Submission 0001193125-23-020487   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 6:32:33.1pm ET